BackXPhyto Therapeutics Overview

XPhyto Therapeutics Current Assets

Track XPhyto Therapeutics's current assets ($1.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$1.29M
↑ 363.09% YoYΔ $1.01M vs prior year quarter

Peer trimmed avg / median

Loading

XPhyto Therapeutics Current Assets History

Loading

XPhyto Therapeutics vs. peers: Current Assets Comparison

Loading

XPhyto Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

XPhyto Therapeutics (4XT.DE) FAQ

As of the most recent data (June 2026), 4XT.DE shows a current assets of $1.3M. That compares with $280K in the prior-year period — up 363.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4XT.DE's current assets is now $1.3M (was $280K) — a 363.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether XPhyto Therapeutics is outperforming or lagging.

Tracking 4XT.DE's current assets over time shows whether XPhyto Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $280K in the prior-year period — up 363.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has XPhyto Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.3M) with ownership activity and broader fundamentals.